{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Inula cappa", "RAW264.7 cells", "UPLC-MS/MS", "cellular pharmacokinetics", "inflammatory model"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36199688", "DateRevised": {"Year": "2022", "Month": "10", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "19"}], "Language": ["eng"], "ELocationID": ["981112", "10.3389/fphar.2022.981112"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Comparative pharmacokinetic study of the five anti-inflammatory active ingredients of <i>Inula cappa</i> in a normal and an LPS-induced inflammatory cell model.", "Pagination": {"StartPage": "981112", "MedlinePgn": "981112"}, "Abstract": {"AbstractText": ["<i>Inula cappa</i> is a commonly used medicine in the Miao area of Guizhou Province in China. We established an <i>in vitro</i> inflammatory model of mouse macrophage RAW264.7 cells to study the different pharmacokinetics of five anti-inflammatory active ingredients in the <i>I. cappa</i> extract namely luteolin (LUT), chlorogenic acid (CA), cryptochlorogenic acid (CCA), 3,4-dicaffeoylquinic acid (3,4-DCQA) and 4,5-dicaffeoylquinic acid (4,5-DCQA), in a normal and an inflammatory cell model. First, RAW264.7 cells were treated <i>in vitro</i> with l\u00a0\u03bcg/mL lipopolysaccharide (LPS) for 24\u00a0h to establish an inflammatory cell model. Then, the pharmacokinetic characteristics of the five ingredients were compared in normal and inflammatory cells after treatment with 200\u00a0\u03bcg/ml and 800\u00a0\u03bcg/ml of <i>I. cappa</i> extracts. After treatment with 1\u00a0\u03bcg/ml LPS for 24\u00a0h, the volume of RAW264.7 cells was increased, the morphology was changed, the antennae were obvious, and the secretion of inflammatory factors nitric oxide and TNF-\u03b1 was increased. The pharmacokinetics results showed that the five ingredients in normal and inflammatory cells exhibited an increase in C<sub>max</sub> and AUC values with increasing doses, and the C<sub>max</sub> and AUC values of five ingredients were positively correlated with the extract concentration. Each of these five ingredients presented nonlinear pharmacokinetic characteristics. After treatment with 200\u00a0\u03bcg/ml of <i>I. cappa</i> extract, the uptake of five ingredients increased in inflammatory cells, T<sub>max</sub> was prolonged, MRT and t<sub>1/2</sub> were prolonged, and CL_F and Vz_F were decreased, while after treatment with 800\u00a0\u03bcg/ml of <i>I. cappa</i> extract, the uptake of five ingredients decreased, T<sub>max</sub> was prolonged, absorption was faster, and MRT and t<sub>1/2</sub> were prolonged. The five analyzed components in <i>I. cappa</i> extract exerted different effects on normal cells and LPS-induced inflammatory cells. Compared to normal cells, the uptake of five ingredients in inflammatory cells was faster and the AUC and C<sub>max</sub> values increased with increasing doses, showing a dose-dependent nonlinear pharmacokinetic profile. These results indicate that the pharmacokinetic effects of the five analyzed ingredients in <i>I. cappa</i> extract are changed in the inflammatory state."], "CopyrightInformation": "Copyright \u00a9 2022 Huang, Chen, Zhou, Zhang, Xue, Li, Zheng, Huang, Wang, Chen and Gong."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Huang", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Chen", "ForeName": "Ruixing", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Zhou", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Zhang", "ForeName": "Qing", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Xue", "ForeName": "Cun", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Li", "ForeName": "Yueting", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Zheng", "ForeName": "Lin", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Huang", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou University of Traditional Chinese Medicine, Guiyang, China."}], "LastName": "Wang", "ForeName": "Qun", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Chen", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Guizhou Medical University, Guiyang, China."}], "LastName": "Gong", "ForeName": "Zipeng", "Initials": "Z"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bao H. S., Hou J. Y., Hu H. J., Li Y. T., Zheng L., Huang Y., et al. (2019). Determination of plasma protein binding rate of nine compounds Inula cappa extraction based on method of equilibrium dialysis. China. J. Chin. Mat. Med. 44 (07), 1475\u20131484. 10.19540/j.cnki.cjcmm.20190116.007", "ArticleIdList": ["10.19540/j.cnki.cjcmm.20190116.007", "31090307"]}, {"Citation": "Bissery M. C., Vrignaud P., Lavelle F., Chabot G. G. (1996). Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice. Anticancer. Drugs 7 (4), 437\u2013460. 10.1097/00001813-199606000-00010", "ArticleIdList": ["10.1097/00001813-199606000-00010", "8826613"]}, {"Citation": "Chang L. L., Qi W. J. (2020). Research progress of Chinese medicine monomer to improve endothelial cell permeability. Beijing Tradit. Chin. Med. 39 (12), 1331\u20131334. 10.16025/j.1674-1307.2020.12.030", "ArticleIdList": ["10.16025/j.1674-1307.2020.12.030"]}, {"Citation": "Chinese Pharmacopoeia Commission (2020). Pharmacopoeia of the people\u2019s Republic of China, Part 1. Beijing: China Medical Science Press, 1715."}, {"Citation": "Dong M., Hiwasa T., Cong B. (2015). Protein kinase C\u03b1-mediated cytotoxic activity of ineupatorolide B from Inula cappa DC HeLa cells. Int. J. Oncol. 47 (5), 1839\u20131844. 10.3892/ijo.2015.3172", "ArticleIdList": ["10.3892/ijo.2015.3172", "26398575"]}, {"Citation": "Feng X. Y., Liu C. D., Zhang Y. M., Kang Z., Jiang Z. T., Yu H. (2019). Determination of plasma protein binding rate of gardenia glycosides, peony glycosides and naringin in gastritis ling granules by equilibrium dialysis. Int. J. Traditional Chin. Med. 41 (06), 608\u2013613. 10.3760/cma.j.issn.1673-4246.2019.06.014", "ArticleIdList": ["10.3760/cma.j.issn.1673-4246.2019.06.014"]}, {"Citation": "Gao L. C., Zhang W., Fan L., Zhou H. H. (2011). Inflammation affects the expression and activity of drug transporters. Chin. Pharmacol. Bul. 27 (01), 7."}, {"Citation": "Gong Z. P., Chen T. T., Hou J. Y., Wu L. L., Li M., Li Y. T., et al. (2017a). Analysis of components in plasma from effective fractions of Inula cappa based on UHPLC/Q-TOF/MS. Chin. Pharmacol. Bul. 33 (11), 1605\u20131610. 10.3969/j.issn.1001-1978.2017.11.025", "ArticleIdList": ["10.3969/j.issn.1001-1978.2017.11.025"]}, {"Citation": "Gong Z. P., Chen Y., Zhang R. J., Wang Y. H., Guo Y., Yang Q., et al. (2014). Pharmacokinetic comparison of berberine in rat plasma after oral administration of berberine hydrochloride in normal and post inflammation irritable bowel syndrome rats. Int. J. Mol. Sci. 15 (1), 456\u2013467. 10.3390/ijms15010456", "ArticleIdList": ["10.3390/ijms15010456", "PMC3907819", "24451127"]}, {"Citation": "Gong Z. P., Li M., Xiong D. F. F., Wu L. L., Liu T., Lan Y. Y., et al. (2017b). Evaluation of anti-inflammatory activity of Inula Cappa extract based on inflammation model in vitro and in vivo . Nat. Prod. Res. Dev. 29 (12), 2050\u20132055."}, {"Citation": "Gong Z. P., Xiong D. F. F., Li M., Wu L. L., Chen T. T., Li Y. T., et al. (2017c). Analysis of chemical constituents of effective components of Inula cappa. J. Anhui. Agri.Sci. 45 (29), 131\u2013133. 10.13989/j.cnki.0517-6611.2017.29.041", "ArticleIdList": ["10.13989/j.cnki.0517-6611.2017.29.041"]}, {"Citation": "Guan H. Y., Lan Y. Y., Liao S. G., Liu J. H., Han Y., Zheng L., et al. (2014). Caffeoylquinic acid derivatives in. Inula cappa Nat. Prod. Res. Dev. 26 (12), 1948\u20131952. 10.16333/j.1001-6880.2014.12.010", "ArticleIdList": ["10.16333/j.1001-6880.2014.12.010"]}, {"Citation": "Guangxi Zhuang Autonomous Region, Department of Health (1992). in Guangxi herbal medicine standard (Nanning: Guangxi Science and Technology Press; ), 49."}, {"Citation": "Guizhou Province Drug Administration (2003). Quality standards for Chinese herbal medicines and ethnic medicines in Guizhou Province. Beijing: China Medical Science and Technology Press, 176."}, {"Citation": "Hu L., He Z. S. (2012). Advances in chemical composition and pharmacological activity of Inula cappa . Chin. J. Mod. Appl. Pharm. 29 (10), 889\u2013894. 10.13748/j.cnki.issn1007-7693.2012.10.008", "ArticleIdList": ["10.13748/j.cnki.issn1007-7693.2012.10.008"]}, {"Citation": "Hunan Food and Drug Administration (2010). Standard for Chinese herbal medicines in Hunan Province (2009 edition). Changsha: Hunan Science and Technology Publishing House, 340."}, {"Citation": "Jiraporn N., Puttinan M., Yingmanee T. (2011). Inhibition of Inula cappa(Ham.ex D.Don) DC.extracts on herpes simplex virus infection in vitro . Afri. J. Microbiol. Res. 5 (24), 4049\u20134058. 10.5897/AJMR10.387", "ArticleIdList": ["10.5897/AJMR10.387"]}, {"Citation": "Li F. L. (2017). Anti-inflammatory effect and mechanism of aqueous extract of Inula cappa on rats with severe pneumonia caused by Klebsiella pneumonia. World. Chin. Med. 12 (10), 2438\u20132442. 10.3969/j.issn.1673-7202.2017.10.041", "ArticleIdList": ["10.3969/j.issn.1673-7202.2017.10.041"]}, {"Citation": "Liu D. C., Zhou F., Zhang J. W., Wang G. J. (2021). New insight and new methodology for herb-drug interactions based on cellular pharmacokinetics. J. Nanjing. Univ. Tradit. Chin. Med. 37 (03), 325\u2013330. 10.14148/j.issn.1672-0482.2021.0325", "ArticleIdList": ["10.14148/j.issn.1672-0482.2021.0325"]}, {"Citation": "Liu J. P. (2016). Biopharmacology and pharmacokinetics. Beijing: People's Health Publishing House, 245."}, {"Citation": "Liu J. Y., Geng T., Duan K., Gao X., Huang C. J., Wang J. J., et al. (2019). Cellular pharmacokinetics and pharmacodynamics mechanisms of ginkgo diterpene lactone and its modulation of P-glycoprotein expression in human SH-SY5Y cells. Biomed. Chromatogr. 33 (12), 4692\u20134706. 10.1002/bmc.4692", "ArticleIdList": ["10.1002/bmc.4692", "31452210"]}, {"Citation": "Liu S. G., Hu X., Liu X., Deng L. (2009). Study on the chemical composition of volatile oil and its role in scavenging free radicals of Inula Cappa. J. Anhui. Agri.Sci. 37 (26), 12536\u201312537. 10.13989/j.cnki.0517-6611.2009.26.148", "ArticleIdList": ["10.13989/j.cnki.0517-6611.2009.26.148"]}, {"Citation": "Liu W. J., Ge T., Liu S. G., Liu X. R. (2010). Extraction and antibacterial effects of flavonoids from Inula Cappa. Hubei Agric. Sci. 49 (02), 426\u2013429. 10.14088/j.cnki.issn0439-8114.2010.02.072", "ArticleIdList": ["10.14088/j.cnki.issn0439-8114.2010.02.072"]}, {"Citation": "Ma Q., Zhang X. L., Wang C. Y., Guo L., Zhao Y. J., Hou Y. L., et al. (2019). Ginsenoside Rb1 regulates cerebral microvascular NOS/NO to improve brain cell membrane permeability. Prog. Mod. Biomed. 19 (08), 1430\u20131435. 10.13241/j.cnki.pmb.2019.08.007", "ArticleIdList": ["10.13241/j.cnki.pmb.2019.08.007"]}, {"Citation": "Mai Q. Y., Fan Y. W., Deng Z. Y., Zhang B. (2021). Mechanism of non-covalent interaction between fetal bovine serum and centaureidin-3-glucoside and its effect on antioxidant activity. Food Sci. 42 (05), 1\u20138. 10.7506/spkx1002-6630-20200108-096", "ArticleIdList": ["10.7506/spkx1002-6630-20200108-096"]}, {"Citation": "Mateus Andr\u00e9., Matsson P\u00e4r., Artursson Per. (2013). Rapid measurement of intracellular unbound drug concentrations. Mol. Pharm. 10 (6), 2467\u20132478. 10.1021/mp4000822", "ArticleIdList": ["10.1021/mp4000822", "23631740"]}, {"Citation": "Ni P., Zhang J. W., Liu J. L., Chen Q. Y., Wang G. J., Zhou F. (2014). Research progress in cellular pharmacokinetic. Prog. Pharm. Sci. 38 (12), 881\u2013885."}, {"Citation": "Patrick P., Frank J., Burczynski S. H. (2016). The role of extracellular binding proteins in the cellular uptake of drugs: Impact on quantitative in vitro -to- in vivo extrapolations of toxicity and efficacy in physiologically based pharmacokinetic-pharmacodynamic research. J. Pharm. Sci. 105 (2), 497\u2013508. 10.1002/jps.24571", "ArticleIdList": ["10.1002/jps.24571", "26173749"]}, {"Citation": "Projean D., Dautrey S., Vu H. K., Groblewski T., Brazier J. L., Ducharme J. (2005). Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain. Pharm. Res. 22 (1), 62\u201370. 10.1007/s11095-004-9010-6", "ArticleIdList": ["10.1007/s11095-004-9010-6", "15771231"]}, {"Citation": "Qiu D. W., Du J. (2005). Chinese materia medica: Miao medicine volume. Guiyang. Guiyang: Guizhou Science and Technology Publishing House, 273\u2013274."}, {"Citation": "Song F., Yang J., Wang C., Wang X., Li W. W., Pan J., et al. (2019). Effect of Inula cappa on CYP450 enzyme in rats by cocktail probe drugs. Chin. J. Expe. Tradi. Med. Formu. 25 (02), 60\u201367. 10.13422/j.cnki.syfjx.20181905", "ArticleIdList": ["10.13422/j.cnki.syfjx.20181905"]}, {"Citation": "Uno S., Fujii A., Komura H., Kawase A., Iwaki M. (2008). Prediction of metabolic clearance of diclofenac in adjuvant-induced arthritis rats using a substrate depletion assay. Xenobiotica 38 (5), 482\u2013495. 10.1080/00498250801935982", "ArticleIdList": ["10.1080/00498250801935982", "18421622"]}, {"Citation": "Wang A. M., Li M., Sun J., Xiong D. F. F., Chen T. T., Wu L. L., et al. (2018). Study on the antibacterial and anti-inflammatory activities of extracts of Inula cappa . LiShiZhen.Med. Mater. Medica. Res. 29 (07), 1580\u20131584."}, {"Citation": "Wang L. H., Feng Y., Zhong S., Zhu Y. P., Lou Y. H., Jiao B. H., et al. (2001). Toll-like receptor antibodies inhibit phagocytic activity of lipopolysaccharide-activated macrophages. Adv. Biochem. Biophysics (03), 367\u2013371. 10.3321/j.issn:1000-3282.2001.03.022", "ArticleIdList": ["10.3321/j.issn:1000-3282.2001.03.022"]}, {"Citation": "Wu J. W., Tang C. P., Cai Y. Y., Ke C. Q., Lin L. G., Yao S., et al. (2017). Cytotoxic germacrane-type sesquiterpene lactones from the whole plant of Inula cappa. Chin. Chem. Lett. 28 (5), 927\u2013930. 10.1016/j.cclet.2016.11.011", "ArticleIdList": ["10.1016/j.cclet.2016.11.011"]}, {"Citation": "Wu Z. J., Lei S., Lu M., Shen Y. H., Tang J., Zhang W. D. (2010). Chemical constituents from Inula cappa . Chem. Nat. Compd. 46 (2), 298\u2013300. 10.1007/s10600-010-9595-4", "ArticleIdList": ["10.1007/s10600-010-9595-4"]}, {"Citation": "Xie H. G., Zhang H. W., Zhang J., Xu L. Z., Zhou Z. M. (2007). The chemical composition of. Inula cappa Chin. Nat. Med. (03), 193\u2013196. 10.3321/j.issn:0513-4870.1999.03.012", "ArticleIdList": ["10.3321/j.issn:0513-4870.1999.03.012"]}, {"Citation": "Xie H. T., Wang G. J., Zhao X. C., Sun J. G. (2004). Uptake and metabolism of ginsenoside Rg3 by Caco-2 cells. Chin. J. Clin. Pharmacol. Ther. 9 (3), 257\u2013260. 10.3969/j.issn.1009-2501.2004.03.005", "ArticleIdList": ["10.3969/j.issn.1009-2501.2004.03.005"]}, {"Citation": "Xie H. T., Wang J., Chen Z. D., Yuan G. Q., Li Q. Q., Lin W. (2012). Analysis of antimicrobial substances and their antibacterial properties of Inula cappa . Nat. Prod. Res. Dev. 24 (11), 1534\u20131537. 10.16333/j.1001-6880.2012.11.021", "ArticleIdList": ["10.16333/j.1001-6880.2012.11.021"]}, {"Citation": "Xue C., Hu H. J., Xiao H. Q., Hou J. Y., Zhang Q., Wang G. C., et al. (2020). Uptake and transport of the nine active components from Inula cappa extract in caco-2 cell model. Lat. Am. J. Pharm. 39 (8), 1579\u20131587."}, {"Citation": "Yao B., Liang X. Y. (2008). Study on the volatile oil composition of Inula cappa. J. Yunnan Univ. Traditional Chin. Med. 31 (06), 27\u201329. 10.3969/j.issn.1000-2723.2008.06.010", "ArticleIdList": ["10.3969/j.issn.1000-2723.2008.06.010"]}, {"Citation": "Yao L. C. (2017). Research on chemical composition and quality standard of Inula cappa. Chengdu: Chengdu University of Traditional Chinese Medicine."}, {"Citation": "Ye M., Zhu Z., Fu Q., Shen K., Li D. K. (2020). Nonlinear pharmacokinetic study of paclitaxel in patients treated with chemotherapy for ovarian cancer. Chin. Pharm. J. (09), 28\u201330. 10.3321/j.issn:1001-2494.2000.09.011", "ArticleIdList": ["10.3321/j.issn:1001-2494.2000.09.011"]}, {"Citation": "Yunnan Food and Drug Administration (2007). Yunnan provincial standard for Chinese materia medica (2005 edition), book 2 Yi medicine, 57. Kunming: Yunnan Science and Technology Publishing House."}, {"Citation": "Zhang Q., Cong D. H., An D. C., Liu Q., et al. (2018). Determination of oroxylin A and oroxylin A 7- O-d-glucuronide in HepG2 cell lysate and subcellular fractions with SPE-UPLC\u2013MS/MS: Cellular pharmacokinetic study to indicate anti-cancer mechanisms. J. Pharm. Biomed. Anal. 154, 364\u2013372. 10.1016/j.jpba.2018.03.019", "ArticleIdList": ["10.1016/j.jpba.2018.03.019", "29571134"]}, {"Citation": "Zhang X. M., An D. W., Zhang H., Yang N. H., Guligena S. (2020). Effect and mechanism of Ziziphora clinopodioides Favonoids on secretion of inflammatory factors from Lipopolysaccharide Induced RAW264.7 cells. Liaoning. J.Traditional. Chin. Med. 47 (02), 158\u2013161. 10.13192/j.issn.1000-1719.2020.02.049", "ArticleIdList": ["10.13192/j.issn.1000-1719.2020.02.049"]}, {"Citation": "Zhang Y., Jiang R. Z. (2018). Research progress on the relationship between HIF2\u03b1 and cell permeability. J. Med.Res. 47 (01), 13\u201315. 10.11969/j.issn.1673-548X.2018.01.004", "ArticleIdList": ["10.11969/j.issn.1673-548X.2018.01.004"]}, {"Citation": "Zhang Z. Y., Hu H. J., Xiong D. F. F., Li Y. T., Huang Y., Zheng L., et al. (2019). Study on quality control of Miao medicine Inula cappa based on anti-inflammatory active ingredients. Chin. Traditional.erb. Drugs. 50 (22), 5571\u20135576. 10.7501/j.issn.0253-2670.2019.22.027", "ArticleIdList": ["10.7501/j.issn.0253-2670.2019.22.027"]}, {"Citation": "Zhou F., Zhang J. W., Li P., Wu X. L., Wang G. J., et al. (2011). Toward a new age of cellular pharmacokinetics in drug discovery. Drug Metab. Rev. 43 (3), 335\u2013345. 10.3109/03602532.2011.560607", "ArticleIdList": ["10.3109/03602532.2011.560607", "21395404"]}, {"Citation": "Zhou F., Zhang Y. B., Zheng X., Lin H. Y. (2019). Effect of white tea extract on LPS-induced inflammation in RAW264.7 cells. Tea. Lett. 46 (04), 455\u2013462."}, {"Citation": "Zhou H., Zheng L. T., Lin A. H., Liu Y. M. (2020). Determination of the pharmacokinetics of mangostin in INS-1 cells by LC-MS/MS. Chin. Pharmacol. Bul. 36 (07), 1024\u20131029. 10.3969/j.issn.1001-1978.2020.07.024", "ArticleIdList": ["10.3969/j.issn.1001-1978.2020.07.024"]}, {"Citation": "Zhou J., Xue C., Zhang Q., Chen S. Y., Chen Y., Huang J., et al. (2022). Establishment of a method determining the contents of seven anti-inflammatory active components of the Miao medicine Inula cappa in Raw 264.7 cells. J. Jiangsu Univ. Ed. 32 (6). 10.13312/j.issn.1671-7783.y220071", "ArticleIdList": ["10.13312/j.issn.1671-7783.y220071"]}, {"Citation": "Zhou W., Wang X., Fu S. H., Sun X., Chen S. Y., Lan Y. Y., et al. (2017). Chemical constituents of Inula cappa. Chin. Pharm. J. 52 (01), 25\u201330. 10.1002/cbdv.200690041", "ArticleIdList": ["10.1002/cbdv.200690041"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "29"}, {"Year": "2022", "Month": "8", "Day": "8"}, {"Year": "2022", "Month": "10", "Day": "6", "Hour": "2", "Minute": "11"}, {"Year": "2022", "Month": "10", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "7", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "9", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["36199688", "PMC9527281", "10.3389/fphar.2022.981112", "981112"]}}], "PubmedBookArticle": []}